A genomic scan for age at onset of Alzheimer's disease in 437 families from the NIMH genetic initiative

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 6, 2008, Pages 784-792

  Dickson, M Ryan ^a   Li, Jian ^a   Wiener, Howard W ^a   Perry, Rodney T ^a   Blacker, Deborah ^b,c   Bassett, Susan S ^d   Go, Rodney C P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzhiemer's disease; Censored quantitative trait; Variance component linkage analysis

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOME; DEGENERATIVE DISEASE; FAMILY STUDY; GENETIC LINKAGE; GENOME; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; ONSET AGE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; STATISTICAL MODEL; SURVIVAL RATE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; FAMILY; FEMALE; GENETICS, POPULATION; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); UNITED STATES;

EID: 51449099154     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30689     Document Type: Article

References (50)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. 2002. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30(1):97-101.
2. Almasy L, Blangero J. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211.
3. Amos CI, Shete S, Gu X. 2001. Variance components analysis for genetic linkage of time to onset for disease. Genet Epidemiol 21(Suppl 1):S768-S773.
4. Bertram L, Tanzi RE. 2004. The current status of Alzheimer's disease genetics: What do we tell the patients? Pharmacol Res 50(4):385-396.
5. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis MG, Go RC, Vekrellis K., et al. 2000. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290(5500):2302-2303.
6. Bertram L, Mullin K, Parkinson M, Hsiao M, Moscarillo TJ, Wagner SL, Becker KD, Velicelebi G, Blacker D, Tanzi RE. 2007. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene? J Med Genet 44(1):e63.
7. Beyer K, Lao JI, Latorre P, Ariza A. 2005. Age at onset: An essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Ann N Y Acad Sci 1057:260-278.
8. Bickeboller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, Penet C, Martin C, Perez-Tur J, Michon A., et al. 1997. Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex. Am J Hum Genet 60(2):439-446.
9. Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF. 1994. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol 51(12):1198-1204.
10. Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE, Perry RT, Bassett SS, Chase G, Meyers D, et al. 1997. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative. Neurology 48(1):139-147.
11. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, et al. 2003. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12(1):23-32.
12. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, et al. 2007. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 68(4):613-618.
13. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261(5123):921-923.
14. Daw EW, Heath SC, Wijsman EM. 1999. Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees. Am J Hum Genet 64(3):839-851.
15. Daw EW, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM. 2000. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66(1):196-204.
16. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG. 2000. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290(5500):2303-2304.
17. Ertekin-Taner N, Ronald J, Asahara H, Younkin L, Hella M, Jain S, Gnida E, Younkin S, Fadale D, Ohyagi Y, et al. 2003. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Hum Mol Genet 12(23):3133-3143.
18. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278(16):1349-1356.
19. Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA, Posner SF, Viitanen M, Winblad B, Ahlbom A. 1997. Heritability for Alzheimer's disease: The study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci 52:M117-M125.
20. Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell TJ, Cherny S, Doil L, et al. 2006. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet 78(1):78-88.
21. Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R, Stone D, Schadt E, et al. 2007. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet 16(8):865-873.
22. Hagnell O, Ojesjo L, Rorsman B. 1992. Incidence of dementia in the Lund by Study. Neuroepidemiology 11(Suppl 1):61-66.
23. Hauser ER, Hsu FC, Daley D, Olson JM, Rampersaud E, Lin JP, Paterson AD, Poisson LM, Chase GA, Dahmen G, et al. 2003. Effects of covariates: A summary of Group 5 contributions. Genet Epidemiol 25:S43-S49.
24. Holmans P, Hamshere M, Hollingworth P, Rice F, Tunstall N, Jones S, Moore P, Wavrant DeVrieze F, Myers A, Crook R., et al. 2005. Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. Am J Med Genet Part B 135B(1):24-32.
25. Janssens B, Goossens S, Staes K, Gilbert B, van Hengel J, Colpaert C, Bruyneel E, Mareel M, van Roy F. 2001. Alpha T-catenin: A novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion. J Cell Sci 114(Pt 17):3177-3188.
26. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC. 2004. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Arch Gen Psychiatry 61(5):518-524.
27. Kim KY, Wood BE, Wilson MI. 2005. Risk factors for Alzheimer's disease: An overview for clinical practitioners. Consult Pharm 20(3):224-230.
28. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. 1996. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 58(6):1347-1363.
29. Li H. 2002. An additive genetic gamma frailty model for linkage analysis of diseases with variable age of onset using nuclear families. Lifetime Data Anal 8(4):315-334.
30. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, et al. 2002. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70(4):985-993.
31. Li YJ, Scott WK, Zhang L, Lin PI, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL, et al. 2006. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases. Neurobiol Aging 27(8):1087-1093.
32. Mayeux R, Lee JH, Romas SN, Mayo D, Santana V, Williamson J, Ciappa A, Rondon HZ, Estevez P, Lantigua R, et al. 2002. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am J Hum Genet 70(1):237-243.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7):939-944.
34. Meyer JM, Breitner JC. 1998. Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. Am J Med Genet 81(1):92-97.
35. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L. 2002. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology 58(2):209-218.
36. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, Marshall H, Meyer D, Shears S, Booth J, et al. 2002. Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 114(2):235-244.
37. Pankratz VS, de Andrade M, Therneau TM. 2005. Random-effects Cox proportional hazards model: General variance components methods for time-to-event data. Genet Epidemiol 28(2):97-109.
38. Pedersen NL, Posner SF, Gatz M. 2001. Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: Findings in Swedish twins. Am J Med Genet 105(8):724-728.
39. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, et al. 1997. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278(15):1237-1241.
40. Poduslo SE, Yin X. 2001. Chromosome 12 and late-onset Alzheimer's disease. Neurosci Lett 310(2-3):188-190.
41. Rocchi A, Pellegrini S, Siciliano G, Murri L. 2003. Causative and susceptibility genes for Alzheimer's disease: A review. Brain Res Bull 61(1):1-24.
42. Rogaeva E, Premkumar S, Song Y, Sorbi S, Brindle N, Paterson A, Duara R, Levesque G, Yu G, Nishimura M, et al. 1998. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 280(7):614-618.
43. Schaid DJ, Olson JM, Gauderman WJ, Elston RC. 2003. Regression models for linkage: Issues of traits, covariates, heterogeneity, and interaction. Hum Hered 55(2-3):86-96.
44. Scott WK, Grubber JM, Abou-Donia SM, Church TD, Saunders AM, Roses AD, Pericak-Vance MA, Conneally PM, Small GW, Haines JL. 1999. Further evidence linking late-onset Alzheimer disease with chromosome 12. JAMA 281(6):513-514.
45. Scurrah KJ, Palmer LJ, Burton PR. 2000. Variance components analysis for pedigree-based censored survival data using generalized linear mixed models (GLMMs) and Gibbs sampling in BUGS. Genet Epidemiol 19(2):127-148.
46. Tanzi RE. 1999. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J Clin Invest 104(9):1175-1179.
47. Wijsman EM, Amos CI. 1997. Genetic analysis of simulated oligogenic traits in nuclear and extended pedigrees: Summary of GAW10 contributions. Genet Epidemiol 14:719-735.
48. Wu WS, Holmans P, Wavrant-DeVrieze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Perez-Tur J, Roehl K, et al. 1998. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 280(7):619-622.
49. Yoo B, Pankratz VS, de Andrade M. 2001. Practical application of residuals from survival models in quantitative trait linkage analysis. Genet Epidemiol 21(Suppl 1):S811-S816.
50. Zeegers M, Rijsdijk F, Sham P. 2004. Adjusting for covariates in variance components QTL linkage analysis. Behav Genet 34(2):127-133.